EGFR and central nervous system cancer: We also found significant enrichments of EGFR-mutated IDHwt (FDR = 7.03E-10) and IDH1-mutated IDHmut-codel gliomas (FDR = 0.020) in later-onset cases (Figures 2C and S2C).